Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia

Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia

Abstract B-cell chronic lymphocytic leukaemia (CLL) is associated with immunosuppression and patients are at increased clinical risk following SARS-CoV-2 infection. Covid-19 vaccines offer the potential for protection against severe infection but relatively little is known regarding the profile of t...

Full description

Bibliographic Details
Main Authors: H. Parry, G. McIlroy, R. Bruton, M. Ali, C. Stephens, S. Damery, A. Otter, T. McSkeane, H. Rolfe, S. Faustini, N. Wall, P. Hillmen, G. Pratt, S. Paneesha, J. Zuo, A. Richter, P. Moss
Format: Article
Language:English
Published: Nature Publishing Group 2021-07-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-021-00528-x

Internet

https://doi.org/10.1038/s41408-021-00528-x

Similar Items